glp 1 agonists and sglt2 inhibitors combination Diabetic Agents, From Metformin to GLP1 Receptor Agonists: JACC Focus Seminar Combining glucagon-like peptide-1 receptor agonists

13 Two meta-analyses of other GLP-1 RA CVOTs found that GLP-1 RAs were associated with greater rates of DR progression, but both studies found that the effect was driven by the extent of hemoglobin A1c reduction, rather than the medications themselves

Given the prescription nature of Direct Meds pharmacy services, refund policies differ from standard product returns

Additionally, incretin therapies can have overbearing negative side effects including hypoglycaemia (often in combination with other glucose-lowering treatments), nausea, vomiting, gastrointestinal upset (including diarrhoea) and injection site reactions that contribute to therapy discontinuation (Trujillo et al., 2021)

90 mg: -3.26%, p=0.0013), and plasma glucose (45 mg: -2.70, p=0.01

Comparator Selection : Many trials use placebo comparisons rather than active comparators, limiting understanding of relative effectiveness compared to existing obesity treatments